# Implantable Vagus Nerve Stimulation Modulation of Coeruleus-Norepinephrine Network for Mild-Moderate AD Patients

> **NCT05575271** · NA · NOT_YET_RECRUITING · sponsor: **Xuanwu Hospital, Beijing** · enrollment: 6 (estimated)

## Conditions studied

- Alzheimer Disease

## Interventions

- **PROCEDURE:** Vagus Nerve Stimulation Modulation of the Coeruleus-Norepinephrine Network

## Key facts

- **NCT ID:** NCT05575271
- **Lead sponsor:** Xuanwu Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2022-11-01
- **Primary completion:** 2026-09-01
- **Final completion:** 2026-12-31
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2022-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05575271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05575271, "Implantable Vagus Nerve Stimulation Modulation of Coeruleus-Norepinephrine Network for Mild-Moderate AD Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05575271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*